Inovio Pharmaceuticals (INO) Posts Narrwer than Expected Q4 Loss; Revs Light
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $0.87 +12.99%
Financial Fact:
Net loss attributable to Inovio Pharmaceuticals, Inc.: -20.76M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Net loss attributable to Inovio Pharmaceuticals, Inc.: -20.76M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Inovio Pharmaceuticals, Inc. (AMEX: INO) reported Q4 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $2.1 million.
For earnings history and earnings-related data on Inovio Pharmaceuticals, Inc. (INO) click here.
For earnings history and earnings-related data on Inovio Pharmaceuticals, Inc. (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- DA Davidson Reiterates Neutral Rating on Nebius Group (NBIS)
- Azitra, Inc. (AZTR) Tops Q2 EPS by 54c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
